Marijn M. Speeckaert

Creatinine determination according to Jaffe--what does it stand for?

Joris Delanghe, Marijn M. Speeckaert · Clinical Kidney Journal · 2011 · 257 citations · Full text

Life Sciences, Biochemistry, Chemistry +9

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease

Tessa Gryp, Kim De Paepe, Raymond Vanholder et al. · Kidney International · 2020 · 204 citations · Full text

Life Sciences, Biochemistry, Metabolomics +11

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17